Trials / Completed
CompletedNCT01449422
Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers.
Evaluation Of The Efficacy, Tolerance And Acceptability Of URGO Dressing 310 3082 Versus A Hydrofibre Dressing In The Local Management Of Venous Or Predominantly Venous Mixed Leg Ulcers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 159 (actual)
- Sponsor
- Laboratoires URGO · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this trial is to demonstrate that a local care strategy using URGO 310 3082 dressing is not inferior to a reference therapeutic strategy using a hydrofibre dressing in the management of venous ulcers. This non-inferiority hypothesis will be judged on the planimetric relative regression of the wound surface area after six weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Dressing | the dressing should be changed on average every 1 to 2 days, then as often as required (up to 7 days) depending on the exudate volume and the clinical condition of the wound (evaluated by the investigating doctor). |
| DEVICE | Dressing | the hydrofibre dressing should be changed when it is saturated, or depending on the clinical appreciation of the situation. The dressing can remain in place for up to 7 days. |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-01-01
- First posted
- 2011-10-10
- Last updated
- 2013-03-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01449422. Inclusion in this directory is not an endorsement.